{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:41:02Z","timestamp":1758588062838,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.taap.2020.115016","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T11:32:31Z","timestamp":1587382351000},"page":"115016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia"],"prefix":"10.1016","volume":"398","author":[{"given":"Laura I.","family":"Kornblihtt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda C.","family":"Cabral Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin L.","family":"Gil Folgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clelia J.","family":"Minissale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Malusardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2375-0077","authenticated-orcid":false,"given":"Guillermo A.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2020.115016_bb0005","doi-asserted-by":"crossref","first-page":"44832","DOI":"10.18632\/oncotarget.6265","article-title":"Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kdelta or PKCbeta signaling pathways","volume":"6","author":"Amigo-Jimenez","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2020.115016_bb0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41571-019-0239-8","article-title":"Chronic lymphocytic leukaemia: from genetics to treatment","volume":"16","author":"Bosch","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.taap.2020.115016_bb0015","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.ejca.2014.09.012","article-title":"Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine","volume":"50","author":"Cavaliere","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.taap.2020.115016_bb0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2020.115016_bb0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2020.115016_bb0030","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3892\/or.2013.2377","article-title":"Pharmacological agents with inherent anti-autophagic activity improve the cytotoxicity of imatinib","volume":"29","author":"Crowley","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2020.115016_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2018.12.003","article-title":"Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: how much do we actually know?","volume":"134","author":"Galicia-Vazquez","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.taap.2020.115016_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41408-017-0039-2","article-title":"Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition","volume":"8","author":"Galicia-Vazquez","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.taap.2020.115016_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cdd.2014.137","article-title":"Essential versus accessory aspects of cell death: recommendations of the NCCD 2015","volume":"22","author":"Galluzzi","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2020.115016_bb0050","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00018-016-2209-y","article-title":"Regulated cell death and adaptive stress responses","volume":"73","author":"Galluzzi","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2020.115016_bb0055","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41580-018-0068-0","article-title":"Linking cellular stress responses to systemic homeostasis","volume":"19","author":"Galluzzi","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2020.115016_bb0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/physrev.00005.2018","article-title":"Evolving and expanding the roles of mitophagy as a homeostatic and pathogenic process","volume":"99","author":"Gustafsson","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2020.115016_bb0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2105-10-106","article-title":"Flowcore: a Bioconductor package for high throughput flow cytometry","volume":"10","author":"Hahne","year":"2009","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.taap.2020.115016_bb0070","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2019 update on diagnosis, risk stratification and treatment","volume":"11","author":"Hallek","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.taap.2020.115016_bb0075","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.taap.2020.115016_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199970","article-title":"18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer","volume":"13","author":"Heiden","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2020.115016_bb0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/10428194.2013.802779","article-title":"Involvement of oxidative stress associated with glutathione depletion and p38 mitogen-activated protein kinase activation in arsenic disulfide-induced differentiation in HL-60 cells","volume":"55","author":"Hu","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.taap.2020.115016_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells7030021","article-title":"Elucidating the metabolic plasticity of Cancer: mitochondrial reprogramming and hybrid metabolic states","volume":"7","author":"Jia","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.taap.2020.115016_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.17219\/acem\/29264","article-title":"Cytotoxic activity of valproic acid on primary chronic lymphocytic leukemia cells","author":"Karp","year":"2015","journal-title":"Adv. Clin. Exp. Med."},{"year":"2017","series-title":"Practical Guide to Cluster Analysis in R: Unsupervised Machine Learning","author":"Kassambara","key":"10.1016\/j.taap.2020.115016_bb0100"},{"key":"10.1016\/j.taap.2020.115016_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/physrev.00041.2017","article-title":"Defining physiological normoxia for improved translation of cell physiology to animal models and humans","volume":"99","author":"Keeley","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2020.115016_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/leu.2015.187","article-title":"Metabolic plasticity in CLL: adaptation to the hypoxic niche","volume":"30","author":"Koczula","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.taap.2020.115016_bb0115","article-title":"El \u00e1cido valproico y la vincristina sensibilizan las c\u00e9lulas de la LLC al ars\u00e9nico combinado con un inhibidor del proteasoma por inhibici\u00f3n de la mitofagia","volume":"19","author":"Kornblihtt","year":"2015","journal-title":"Revista Argentina de Hematolog\u00eda"},{"year":"2016","series-title":"Targeting Mitophagy in Combined Therapies of Haematological Malignancies","author":"Kornblihtt","key":"10.1016\/j.taap.2020.115016_bb0120"},{"year":"2012","series-title":"Median Effect Dose and Combination Index Analysis of Cytotoxic Drugs Using Flow Cytometry","author":"Lombardo","key":"10.1016\/j.taap.2020.115016_bb0125"},{"key":"10.1016\/j.taap.2020.115016_bb0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.taap.2011.11.018","article-title":"Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion","volume":"258","author":"Lombardo","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2020.115016_bb0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bcpt.12945","article-title":"Regulated cell death of lymphoma cells after graded mitochondrial damage is differentially affected by drugs targeting cell stress responses","volume":"122","author":"Lombardo","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2020.115016_bb0140","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1242\/jcs.115626","article-title":"Autophagy and microtubules - new story, old players","volume":"126","author":"Mackeh","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.taap.2020.115016_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2019.05.012","article-title":"Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer","volume":"98","author":"Mates","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2020.115016_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148923","article-title":"A lab assembled microcontroller-based sensor module for continuous oxygen measurement in portable hypoxia chambers","volume":"11","author":"Mathupala","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2020.115016_bb0155","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3324\/haematol.2018.207068","article-title":"Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy","volume":"104","author":"Mato","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.taap.2020.115016_bb0160","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10602","article-title":"Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.taap.2020.115016_bb0165","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1074\/jbc.TM117.000893","article-title":"Mitochondrial proteostasis in the context of cellular and organismal health and aging","volume":"294","author":"Moehle","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2020.115016_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2018-02-833475","article-title":"Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy","volume":"133","author":"Nguyen","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.taap.2020.115016_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mito.2016.09.001","article-title":"Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53","volume":"31","author":"Ogasawara","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.taap.2020.115016_bb0180","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1007\/s13277-015-3762-y","article-title":"Metabolic reprogramming as a continuous changing behavior of tumor cells","volume":"36","author":"Peppicelli","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.taap.2020.115016_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.taap.2020.115016_bb0190","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fonc.2018.00556","article-title":"Metabolic reprogramming of non-Hodgkin\u2019s B-cell lymphomas and potential therapeutic strategies","volume":"8","author":"Ricci","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2020.115016_bb0195","doi-asserted-by":"crossref","first-page":"2426712","DOI":"10.1155\/2018\/2426712","article-title":"Targeting mitochondrial bioenergetics as a therapeutic strategy for chronic lymphocytic Leukemia","volume":"2018","author":"Roy Chowdhury","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.taap.2020.115016_bb0200","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/cncr.31931","article-title":"Chronic lymphocytic leukemia (CLL) treatment: so many choices, such great options","volume":"125","author":"Sharma","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2020.115016_bb0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2014.03.006","article-title":"Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts","volume":"112","author":"Sitarz","year":"2014","journal-title":"Mol. Genet. Metab."},{"year":"2018","series-title":"R: A Language and Environment for Statistical Computing","author":"Team","key":"10.1016\/j.taap.2020.115016_bb0210"},{"key":"10.1016\/j.taap.2020.115016_bb0215","article-title":"Induction and testing of hypoxia in cell culture","volume":"54","author":"Wu","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.taap.2020.115016_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pathol-020712-163955","article-title":"The pathogenesis of chronic lymphocytic leukemia","volume":"9","author":"Zhang","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.taap.2020.115016_bb0225","first-page":"1067","article-title":"Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity","volume":"46","author":"Zheng","year":"2015","journal-title":"Int. J. Oncol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2030140X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2030140X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:50:29Z","timestamp":1758574229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2030140X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":45,"alternative-id":["S0041008X2030140X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115016","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115016"}}